The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
My figures for cash per share are my own estimates. Please do your own research. No investment advice intended.
However with a prospective 4.25p cash per share versus current sp of 2.6p, the Vodiac business is valued at zero.
Seems a rare undervalued opportunity.
Any traction for the home entertainment product is icing on the cake.
Clearly the company cannot sustain a workforce of 50 people, on current cash flow.
Reduce staff by 20%.
Perhaps OSI could apply for some government export credit loans. Don’t see why not, the new Chinese owners of Wolves? Just applied and got £80mn.
Bookings growth year on year of 4% is too low. The route to being cash flow positive is being achieved, but at a slow pace.
The gold medal award is a positive , hopefully encouraging new clients,. A £2m fund raise is probably doable, unfortunately dilutive to existing holders. This company could do with some direct government loans; being in such a critical sector.
Let’s hope progress is made and Inl returns from suspension soon. The company of course remains a tempting target.
A farm in for the Kelham structure appraisal well may be a good plan. Perhaps UJO could put some of its cash pile to work.
H2 was never stimulated…. to my understanding.
‘Even after stimulation’……are you sure about that statement.
UK SNSea and the development of the gas reserves, remains important from a UK energy security point of view.
Harbour is freezing its UK offshore oil and gas exploration, so it would seem important to push Centrica or the like, to come to IOG’s aid.
To see a sp at such a discount to cash is unusual. Clearly a comfortable position.. Let’s (sic) hope we do not overpay for any acquisitions.
St Bart’s Hospital has suffered a major hacking incident, reported last week. NHS trusts seek anti hacking protection.
At 3.1p , correct me if I am wrong but this is a low valuation as the company will have 4.75p of cash shortly.